Publications (69) Ricardo Fernández de Misa Cabrera publications

filter_list

2026

  1. Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study

    Journal of the European Academy of Dermatology and Venereology, Vol. 40, Núm. 1, pp. 99-108

2025

  1. Germline PDCDL1 Gene Variants Are Associated with Increased Primary Melanoma Thickness

    Biomolecules, Vol. 15, Núm. 4

  2. Multiple Basal Cell Carcinomas. Timeline and Underlying Risk Factors

    Actas Dermo-Sifiliograficas, Vol. 116, Núm. 8, pp. 815-823

  3. Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real-World Cohort

    International Journal of Dermatology

  4. Safety of sonidegib in elderly patients with locally advanced basal cell carcinoma: A multicentre study

    Journal of the European Academy of Dermatology and Venereology

2024

  1. Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data

    Journal of the European Academy of Dermatology and Venereology

  2. Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma

    BMC Cancer, Vol. 24, Núm. 1

  3. Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): Description and Data in its First Year of Operation

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 7, pp. 663-669

  4. VEGFC Gene Expression Is Associated with Tumor Progression and Disease-Free Survival in Cutaneous Squamous Cell Carcinoma

    International Journal of Molecular Sciences, Vol. 25, Núm. 1

2023

  1. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64

  2. Expression of angiogenic and lymphangiogenic genes in primary cutaneous melanoma: relationship with angiolymphatic invasion and disease-free survival

    Melanoma research, Vol. 33, Núm. 5, pp. 375-387

  3. Ocrelizumab, an alternative to rituximab in refractory pemphigus vulgaris management

    Journal of the European Academy of Dermatology and Venereology

  4. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 4, pp. 291-298

  5. Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 7, pp. T565-T571

2022

  1. Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial

    The Lancet Haematology, Vol. 9, Núm. 6, pp. e425-e433

  2. EORTC-QLQ-C30 and SKINDEX-29 measurement of health-related quality of life in patients with mycosis fungoides and Sézary syndrome: Real-world data in Spanish patients (MICADOS Study)

    JEADV Clinical Practice, Vol. 1, Núm. 4, pp. 438-449

2021

  1. Gene Expression Studies in Formalin-Fixed Paraffin-Embedded Samples of Cutaneous Cancer: The Need for Reference Genes

    Current issues in molecular biology, Vol. 43, Núm. 3, pp. 2167-2176

  2. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology

  3. Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma Registry

    Pediatric Dermatology, Vol. 38, Núm. 6, pp. 1506-1509

2020

  1. Cost of early-stage mycosis fungoides treatments in Spain

    ClinicoEconomics and Outcomes Research, Vol. 12, pp. 91-105